Coronary heart disease, hypercholesterolemia, and atherosclerosis II. Misrepresented data

Experimental and Molecular Pathology

Volumn 70, Issue 2, 2001, Pages 120-139

  Stehbens, William E ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Atherosclerosis; Cholesterol; Coronary heart disease; Epidemiological methods; Hypercholesterolemic lipid hypothesis; Lipid dystrophies; Lipoproteins; Reference range

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE DISTRIBUTION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; DIABETES MELLITUS; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; FAMILIAL DEFECTIVE APOLIPOPROTEIN B100; FAMILIAL HYPERLIPEMIA; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 2; HYPERLIPOPROTEINEMIA TYPE 3; HYPERTENSION; IATROGENIC DISEASE; ISCHEMIC HEART DISEASE; LIPIDOSIS; MONOGENIC DISORDER; MORTALITY; MULTIFACTORIAL INHERITANCE; NONHUMAN; ONSET AGE; RISK FACTOR; SEX DIFFERENCE; VASCULAR LESION;

ANIMALIA;

EID: 0035570763     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1006/exmp.2000.2339     Document Type: Article

References (188)

1. Genetics of atherosclerosis. Studies of families with xanthoma and unselected patients with coronary artery disease under the age of fifty years
2. Special report. The Cholesterol Facts. A summary of the evidence relating dietary fats, serum cholesterol and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute
3. Working report. Conference on the health effects of blood lipids: Optimal distributions for populations
4. Lipoprotein-cholesterol analysis during screening: Accuracy and reliability
5. Is cholesterol testing/treatment really beneficial?
6. Does passive smoking cause heart disease?
7. Les troubles du métabolisme des lipides dans l'athérosclérose humaine
8. Low total cholesterol is associated with high total mortality in patients with coronary heart disease
9. Heart rate: An important risk factor for coronary mortality-Ten-year experience of the Peoples Gas Co
10. Cholesterol values in patients with myocardial infarction and in a normal control group
11. Serum cholesterol in patients with myocardial infarction in younger ages
12. Coronary heart disease in young men: A study of seventy patients with a critical review of etiological factors
13. Hereditary disturbance of cholesterol metabolism: A factor in the genesis of atherosclerosis
14. Myocardial infarction in the familial forms of hypertriglyceridemia
15. Serum lipids in men with myocardial infarction
16. Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol
17. Predictors of mortality in very old subjects aged 80 years or over
18. The fact and fiction of lowering cholesterol concentrations in the primary prevention of coronary heart disease
19. Cardiovascular risk factors in the elderly
20. Serum lipids and risk of coronary artery disease
21. Methodological problems in the study of human populations
22. Lowering blood cholesterol to prevent heart disease
23. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons
24. HDL cholesterol predicts coronary heart disease mortality in older persons
25. Epidemiologic aspects of lipid abnormalities
26. Skin xanthomas in childhood
27. Low blood cholesterol and non-atherosclerotic disease mortality: Where do we stand?
28. The lipid and cholesterol content of the blood of patients with angina pectoris and arteriosclerosis
29. II Coronary heart disease in the Framingham study
30. Intra-individual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humans
31. Plasma lipid levels in survivors from myocardial infarction
32. Prevalence of three major risk factors in random sample of men and women and in patients with ischaemic heart disease
33. Myocardial infarction in young men. Study of risk factors in nine countries
34. Pathology of atherosclerosis
35. Is reduction of blood cholesterol effective?
36. Coronary heart disease without risk factors
37. Coronary artery disease in young women
38. Familial hypercholesterolemia, xanthomatosis and coronary heart disease
39. Diagnostic implications of very low serum cholesterol
40. On a possible inverse relationship between serum cholesterol and cancer mortality
41. Cholesterol as risk factor for mortality in elderly women
42. Analytical goals in clinical biochemistry
43. Generation and application of data on biological variation in clinical chemistry
44. The role of lipids in acute myocardial infarction
45. Risk factors for 5-year mortality in older adults
46. Familial lipoprotein disorders in patients with premature coronary artery disease
47. Age, serum cholesterol and coronary artery heart disease
48. Hypocholesterolemia in substance abusers
49. Low cholesterol concentrations in free-living elderly subjects: Relations with dietary intake and nutritional status
50. The role of lipids and lipoproteins in atherosclerosis
51. Ischemic heart disease, atherosclerosis, and longevity
52. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction
53. Hyperlipidemia in coronary heart disease. II. Genetic delineation of a new inherited disorder, combined hyperlipidemia
54. Cholesterol and violence: Is there a connection?
55. Treating high blood cholesterol in the older patient
56. High density lipoprotein as a protective factor against coronary heart disease
57. Lipoproteins, cardiovascular disease, and death. The Framingham study
58. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease
59. Variations in serum lipid in concentration and clinical coronary disease
60. Serum cholesterol variations in individual patients
61. Cholesterol and coronary heart disease. A new era
62. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease
63. Introduction: Structure and metabolism of plasma lipoproteins
64. Hyperlipidemia in coronary heart disease. III. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction
65. The risk of atherosclerotic vascular disease in subjects with xanthomatosis
66. Lipoprotein-cholesterol distribution in selected North American Populations: The Lipid Research Clinics Program Prevalence study
67. Myocardial infarction in young patients: An analysis by age subsets
68. Cholesterol in the elderly. Is it important?
69. Health policy on blood cholesterol. Time to change direction
70. Circulating cholesterol level and risk of death from cancer in men aged 40 to 69 years
71. Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey
72. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial
73. Report of the conference on low blood cholesterol: Mortality associations
74. Cholesterol and coronary artery disease: Age as an effect modifier
75. Myocardial infarction in the young
76. Coronary disease in familial hypercholesterolemia
77. The biochemistry of blood lipid regulation and the assessemnt of lipid abnormalities
78. Mechanisms and hypocholesterolaemia in hairy cell leukaemia
79. Serum cholesterol and mortality in a Japanese-American population. The Honolulu Heart Program
80. The role of cholesterol in coronary atherogenesis
81. Metabolic risk factors for coronary heart disease in women: Perspective study from the Framingham study
82. Cholesterol and risk of coronary heart disease and mortality in men
83. Discussion
84. Range of serum cholesterol values in the population developing coronary artery disease
85. Cholesterol in the prediction of atherosclerotic disease
86. Serum lipid precursors of coronary heart disease
87. Obesity and nutrition in elderly patients
88. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT
89. The age trend of serum concentrations of cholesterol and of Sf 10-20 ("G") substances in adults
90. Dietary lipids and the low blood cholesterol-cancer association
91. Total serum cholesterol levels and mortality risk as a function of age
92. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years
93. Diet-drug treatment of hyperlipidemia in coronary artery disease. A rational and beneficial approach
94. Authors' reply
95. Cholesterol and beta lipoproteins in the serums of americans
96. Diagnosing familial hypercholesterolaemia in childhood by measuring serum cholesterol
97. Left ventricular mass and incidence of coronary heart disease in an elderly cohort
98. Cardiovascular risks: New insights from Framingham
99. Serum lipoprotein abnormalities in patients with ischaemic heart disease: Comparison with a control population
100. Aortocoronary bypass saphenous vein graft atherosclerosis
101. Growth failure. A complication of dietary treatment of hypercholesterolemia
102. Low serum cholesterol concentration and short term mortality from injuries in men and women
103. Studies of male survivors of myocardial infarctions due to "essential" atherosclerosis. II Lipids and lipoproteins
104. Diet and serum-lipids in male survivors of myocardial infarction
105. Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impaired catabolism
106. The risk of fallacious conclusions from autopsy data on the incidence of diseases with applications to heart disease
107. Serum lipids in young female survivors of myocardial infarction
108. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop
109. Genetic susceptibility to death from coronary heart disease in a study of twins
110. Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361,662 men
111. Within-person fluctuations of serum cholesterol and lipoproteins
112. Cholesterol metabolism: Blood serum cholesterol and ester levels in 200 cases of acute coronary thrombosis
113. The genetic hyperlipidemias
114. Risk factors for coronary atherosclerosis in the elderly
115. Familial defective apoliprotein B-100: A review, including some comparisons with familial hypercholesterolaemia
116. Serum cholesterol and mortality findings for men screened in the multiple Risk Factor Intervention Trial
117. Family study of serum lipids and lipoproteins in coronary heart-disease
118. Characteristics and outcomes of hospitalized older patients who develop hypocholesterolemia
119. Coronary disease, hypercholesterolaemia and its treatment
120. Clinical characteristics and prognosis of angina and myocardial infarction in young women
121. Serum cholesterol - The knave of hearts and the joker
122. The plasma lipids in coronary artery disease
123. Serum lipoprotein patterns in coronary sclerosis and associated conditions
124. The prognostic significance of hypercholesterolemia in hospitalized patients
125. Changes in serum cholesterol level and mortality: A 30-year follow-up
126. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the Pooling Project
127. Cholesterol, diastolic blood pressure, and stroke: 13000 Strokes in 450000 people in 45 prospective cohorts
128. Parental beliefs as a cause of nonorganic failure to thrive
129. Quotation bias reviews of the diet-heart idea
130. Estimation of normal ranges from a controlled sample survey. I. Sex- and age-related influence on the SMA 12/60 screening group of tests
131. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults
132. Cholesterol lowering and the reduction of coronary heart disease risk
133. Familial occurrence of coronary heart disease: Effect of age at diagnosis
134. Measuring cholesterol is as tricky as lowering it
135. Strategy of prevention: Lessons from cardiovascular disease
136. Sick individuals and sick populations
137. Plasma lipids and mortality: A source of error
138. Lipoprotein analysis
139. Coronary heart disease in the Western collaborative group study. A follow-up experience of 42 years
140. Antecedents of death in the men of a Veterans Administration nursing home
141. Prognostic significance of serum cholesterol in nursing home men
142. Cholesterol, violent death, and mental disorder
143. Are low mortality values associated with excess mortality
144. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival study (4S)
145. Serum cholesterol and cancer in the NHANES 1 epidemiological follow-up study
146. Studies of serum cholesterol in 4,244 men and women: An epidemiological and pathogenetic interpretation
147. Familial hypercholesterolemia in a large kindred. Evidence for a monogenic mechanism
148. Fat nutrition and diet in childhood
149. The Framingham heart study shows no increase in coronary heart disease rates from cholesterol values of 205 to 264 mg%
150. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection
151. Risks of ischaemic heart-disease in familial hyperlipo-proteinaemic states
152. Genetic difference in liability to atherosclerotic heart disease
153. The genetic contribution to coronary heart disease through lipoprotein concentrations
154. Is a high serum cholesterol level associated with longer survival in elderly hypertensives?
155. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the multiple Risk Factor Intervention Trial (MRFIT)
156. Prevalence and prognostic significance of hypercholesterolemia in men with hypertension. Perspective data on the primary screenees of the Multiple Risk Factor Intervention Trial
157. Haemodynamic production of lipid deposition, intimal tears, mural dissection and thrombosis in the blood vessel wall
158. The epidemiological relationship of hypercholesterolemia, hypertension, diabetes mellitus and obesity to coronary heart disease
159. Validity of cerebrovascular mortality rates
160. Limitations of the epidemiological method in coronary heart disease
161. Experimental induction of atherosclerosis assosociated with femoral arteriovenous fistulae in rabbits on a stock diet
162. Atherosclerosis and degenerative diseases of blood vessels
163. The pathogenesis of atherosclerosis: A critical evaluation of the evidence
164. Coronary heart disease, hypercholesterolemia and atherosclerosis. I. False premises
165. Venous atherosclerosis associated with arteriovenous fistulas for hemodialysis
166. Cholesterol in arteriosclerosis, with special reference to coronary arteriosclerosis
167. Significance of dietary cholesterol in coronary arteriosclerosis
168. Serum cholesterol level in coronary arteriosclerosis
169. Dyslipidemia as a risk factor for cardiovascular disase and untimely death: The Framingham study
170. Expert panel on detection, education, and treatment of high blood cholesterol in adults (adult treatment panel II)
171. Variation in cholesterol levels
172. Xanthomatoses
173. The variability of serum cholesterol measurements: Implication for screening and monitoring
174. Myth and paradox of coronary risk and the menopause
175. Hypocholesterolemia as a predictor of death: A prospective study of 224 nursing home residents
176. Familial hypercholesterolemia in the Finnish North Kerelia. A molecular, clinical and genealogical study
177. The need for clarification of percent risk reduction data in clinical cardiovascular trial reports
178. Analysis of the MRFIT screenees: A methodological study
179. Total cholesterol and risk of mortality in the oldest old
180. The oxidation hypothesis of atherosclerosis